Table 3. The estimated cost of the different regimens.

Treatment	Drugs (US$)	Tests (US$)	Consultation fees (US$)	Total (US$)
Genotype 2/3: 24-week treatment regimen
IFN α-2a + ribavirin	619.17 – 655.17	498.18	13.95	1,155.29 – 1,167.31
IFN α-2b + ribavirin	607.75 – 619.77	498.18	13.95	1,119.88 – 1,131.90
Peg-IFN α-2a + ribavirin	1,644.14 – 2,617.89	498.18	13.95	2,156.27 – 3,130.02
Peg-IFN α-2b + ribavirin	1,680.07 – 1,967.78	498.18	13.95	2,192.20 – 2,470.91
Genotype 1/4/6: 48-week treatment regimen
IFN α-2a + ribavirin	1,325.52 – 1,333.78	613.24	24.41	1,953.84 – 1,961.90
IFN α-2b + ribavirin	1,254.71 – 1,262.97	613.24	24.41	1,882.83 – 1,892.09
Peg-IFN α-2a + ribavirin	3,327.48 – 5,259.20	613.24	24.41	3,955.60 – 5,887.32
Peg-IFN α-2b + ribavirin	3,375.89 – 3,950.73	613.24	24.41	4,003.43 – 4,578.85

The range in the costs for a given regimen is due to the variation in the costs of the different brands of the drugs and the different dosages (minimum and maximum values are shown in Table 3). Costs are in 2017 prices.